Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,325,870
  • Shares Outstanding, K 37,766
  • Annual Sales, $ 642,990 K
  • Annual Income, $ 126,150 K
  • 36-Month Beta 1.18
  • Price/Sales 11.38
  • Price/Cash Flow 33.19
  • Price/Book 6.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.94
  • Number of Estimates 1
  • High Estimate 0.94
  • Low Estimate 0.94
  • Prior Year 1.13
  • Growth Rate Est. (year over year) -16.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
159.08 +21.93%
on 01/23/19
194.50 -0.28%
on 02/21/19
+30.79 (+18.87%)
since 01/18/19
3-Month
132.75 +46.11%
on 12/24/18
194.50 -0.28%
on 02/21/19
+37.48 (+23.95%)
since 11/21/18
52-Week
132.75 +46.11%
on 12/24/18
206.04 -5.86%
on 09/28/18
+54.41 (+38.99%)
since 02/21/18

Most Recent Stories

More News
Uptrend Call Working As Bio-Techne Corp Stock Rises 31.5% (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 1 month, Bio-Techne Corp has returned 31.52% as of today's recent price of $193.67.

TECH : 193.96 (+0.13%)
Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines

Bio-Techne (TECH) sees increase in revenues across key segments.

TECH : 193.96 (+0.13%)
ABT : 75.14 (-0.53%)
ANGO : 22.43 (-4.31%)
CNMD : 75.14 (+1.93%)
Bio-Techne Corp Shares Up 26.8% Since SmarTrend's Buy Recommendation (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 1 month, Bio-Techne Corp has returned 26.75% as of today's recent price of $186.65.

TECH : 193.96 (+0.13%)
Bio-Techne Corp Up 24.1% Since SmarTrend Uptrend Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 4 weeks, Bio-Techne Corp has returned 24.09% as of today's recent price of $182.73.

TECH : 193.96 (+0.13%)
Techne (TECH) Q2 Earnings and Revenues Surpass Estimates

Techne (TECH) delivered earnings and revenue surprises of 6.00% and 2.57%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

TECH : 193.96 (+0.13%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2018. The quarterly dividend will be payable...

TECH : 193.96 (+0.13%)
Bio-Techne Releases Second Quarter Fiscal 2019 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2018.

TECH : 193.96 (+0.13%)
ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Bio-Techne Corporation (NASDAQ:TECH) today announced the National Comprehensive Cancer Network (NCCN) decision to include EPI as a recommended test in their Clinical Practice Guidelines in Oncology (NCCN...

TECH : 193.96 (+0.13%)
Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TECH : 193.96 (+0.13%)
Bio-Techne Corp Up 11.3% Since SmarTrend Uptrend Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 3 weeks, Bio-Techne Corp has returned 11.28% as of today's recent price of $163.86.

TECH : 193.96 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade TECH with:

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

2nd Resistance Point 196.30
1st Resistance Point 195.13
Last Price 193.96
1st Support Level 192.16
2nd Support Level 190.36

See More

52-Week High 206.04
Last Price 193.96
Fibonacci 61.8% 178.04
Fibonacci 50% 169.39
Fibonacci 38.2% 160.74
52-Week Low 132.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar